| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -8,249 | -9,031 | -10,466 | -22,217 |
| Stock-based compensation | 1,441 | 2,038 | 2,950 | 4,377 |
| Change in operating lease right of use assets | -110 | -102 | -115 | -204 |
| Amortization of acquired intangible assets | 463 | 474 | 473 | 1,884 |
| Depreciation and impairment | 61 | 60 | 73 | 174 |
| Change in fair value of warrant liability | -177 | -778 | -78 | -825 |
| Accrued interest on short term bank deposits | 21 | 14 | NaN | NaN |
| Non-cash financial expenses | 159 | 101 | 167 | 2,665 |
| Decrease (increase) in trade receivables, net | 75 | -231 | -181 | -2,248 |
| Decrease (increase) in other accounts receivable, prepaid expense and long-term assets | 269 | 454 | 14 | -484 |
| Decrease in inventories | -144 | -554 | 260 | -143 |
| Increase (decrease) in trade payables | 535 | -546 | 90 | 334 |
| Decrease in other accounts payable and accrued expenses | -341 | 715 | -637 | -858 |
| Decrease in deferred revenues | -213 | -146 | 133 | -856 |
| Decrease in operating lease liabilities | -116 | -93 | -101 | -147 |
| Other | 15 | 8 | 4 | -654 |
| Net cash used in operating activities | -6,025 | -5,887 | -7,350 | -12,704 |
| Investment in short term bank deposit | 5,000 | 4,200 | NaN | NaN |
| Proceeds from maturity of short-term bank deposit | 4,200 | NaN | NaN | NaN |
| Purchase of property and equipment | 31 | 26 | 41 | 75 |
| Disposals of property and equipment | 5 | NaN | NaN | NaN |
| Net cash used in investing activities | -826 | -4,226 | -41 | -75 |
| Proceeds from issuance of common stock and prefunded warrants, net of issuance costs | NaN | -19 | 17,393 | NaN |
| Proceeds from issuance of preferred stock, net of issuance costs | NaN | 0 | 0 | 6,754 |
| Proceeds from borrowings on credit agreement, net of issuance cost | NaN | 0 | 0 | 31,700 |
| Repayment of long-term loan | NaN | 0 | 0 | 31,515 |
| Net cash provided by financing activities | NaN | -19 | 17,393 | 6,939 |
| Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | -6,851 | -10,132 | 10,002 | -5,840 |
| Effect of exchange rate differences on cash, cash equivalents and restricted cash and cash equivalents | 25 | 28 | -19 | NaN |
| Cash, cash equivalents and restricted cash and cash equivalents at beginning of period | 21,803 | 31,907 | 27,764 | NaN |
| Cash, cash equivalents and restricted cash and cash equivalents at end of period | 14,977 | 21,803 | 31,907 | NaN |
DarioHealth Corp. (DRIO)
DarioHealth Corp. (DRIO)